These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. MDM2 oncogene as a novel target for human cancer therapy. Zhang, Wang H. Curr Pharm Des; 2000 Mar; 6(4):393-416. PubMed ID: 10788589 [Abstract] [Full Text] [Related]
28. Analysis of downstream effectors of p53 on cell growth arrest and apoptosis induced by a temperature-sensitive Val138 mutant. Wang FJ. J Med Dent Sci; 1998 Jun; 45(2):141-9. PubMed ID: 11186200 [Abstract] [Full Text] [Related]
29. Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps. Würl P, Bartel F, Meye A, Kappler M, Bache M, Schmidt H, Schönfelder M, Taubert H. Int J Oncol; 2002 May; 20(5):1087-93. PubMed ID: 11956608 [Abstract] [Full Text] [Related]
30. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53. Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM. Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181 [Abstract] [Full Text] [Related]
35. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines. Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F. Oncogene; 2008 Sep 11; 27(40):5303-14. PubMed ID: 18521084 [Abstract] [Full Text] [Related]